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Abstract 
The efflux of tetraethyl:unmonium (TEA) from suspensions of rabbit renal proximal tubules is completely blocked by 500 /xM 
tetrapentylammonium (TPeA) in the extracellular medium. The basis of this trans-inhibition of TEA transport by TPeA was examined in 
tubule suspensions. At TPeA concentrations < 10 ~M, effiux of TEA was reduced by ~ 50%, whereas at concentrations > 10 /zM, 
TPeA reduced efflux an additional 50% to produce anear complete block of TEA effiux. Increasing concentrations of TPeA from 0-500 
/.,M were found to produce a biphasic, concentration-dependent tra s-inhibition of TEA effiux from tubule suspensions suggesting that 
TPeA may block effiux by binding to both a high and low affinity TPeA binding site. The trans-inhibition of TEA effiux by TPeA at low 
concentrations (< 10 /xM) may result from a slow carrier turnover when TPeA is bound to the carrier site. To determine whether the 
inhibitory effectiveness ofTPeA was also associated with its slow dissociation from the carrier site, the effect of a 10 s preincubation with 
1 /zM TPeA on TEA uptake was examined. The uptake of TEA by tubules preincubated for 10 s with TPeA was reduced by ~ 30-50% 
compared to control tubules not preincubated with TPeA. A 10 s preincubation with 150 /xM unlabeled TEA had no effect on TEA 
uptake compared to control tubules not preincubated with TEA. When the 10 s preincubation with 1 /xM TPeA was followed by a 10 min 
recovery period, TEA uptake returned to control evels, indicating that the prolonged inhibition was reversible. This prolonged inhibition 
of TEA uptake after a 10 s preincubation with 1 /zM TPeA, as suspected, may arise from a slow dissociation of TPeA from the OC 
transporter following a rapid association to the binding site. TPeA inhibition of TEA uptake into tubules was competitive in nature with a 
K i of 1 ~M. The ability of TEA to compete with TPeA for binding to the carrier suggests that the binding of TPeA to the carrier can be 
displaced by large concentrations of TEA. These observations suggest hat the interactions of TPeA, and perhaps similarly large 
hydrophobic OCs, with the OC transporter are complex. 
Keywords: Proximal tubule; Tetrapentylammonium; Tetraethylammonium transport; Organic ation transport; (Rabbit kidney) 
1. Introduction 
The renal secretion of organic cations (OCs) involves 
their translocation from the blood into the cells of proxi- 
mal tubules across the peritubular membrane and their 
subsequent exit across the apical membrane into the urine. 
The entrance of OCs into proximal cells across the per- 
itubular membrane is believed to result from electrogenic, 
facilitated diffusion, driven by the transmembrane electro- 
chemical gradient or, alternatively, electroneutral OC/OC 
exchange, whereas the exit step across the apical mem- 
brane involves the electroneutral exchange of an OC for 
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H + [1]. Studies using intact perfused proximal tubules 
indicate that the apical transport step is probably the 
rate-limiting step in renal secretion of OCs [2]. Recent 
examination of the kinetics of peritubular OC transport in 
both single $2 segments and suspensions of renal proximal 
tubules are consistent with this conclusion: peritubular OC 
transport appears to have both a high affinity and high 
capacity for OCs, compared to the apical transport process 
[31. 
The inhibitory interactions of OCs with the peritubular 
secretory pathway have received limited attention. Ullrich 
and his colleagues have examined the influence of molecu- 
lar structure on the inhibition of peritubular transport of 
NLmethylnicotinamide (NMN) in microperfused rat proxi- 
mal tubules [4-7]. Although a general correlation was 
found between the degree of inhibition of NMN transport 
38 C.E. Groves, S.H. Wright / Biochimica et Biophysica Acta 1234 (1995) 37-42 
and the lipophilicity of the test agent, there were notable 
exceptions. For example, the long chain n-tetraalkylam- 
monium (n-TAA) compounds did not follow this pattern. 
In contrast, our recent work examined the effect of n-TAA 
compounds on the transport of the prototypical OC tetra- 
ethylammonium (TEA) and observed an increase in in- 
hibitory potency with increasing alkyl chain length [3]. Our 
study also noted that the relative rates of peritubular 
transport appeared to decrease with increasing alkyl chain 
length. The lower affinity n-tetraalkylammoniums, such as 
tetramethylammonium (TMA) and tetraethylammonium 
(TEA) at a concentration f 500 /xM increased the effiux 
of [a4C]TEA from tubule suspensions, (i.e., trans-stimu- 
lated), which suggests that these agents are substrates for 
the OC transporter. However, a 500 /~M concentration f
tetrapentylammonium (TPeA), a high affinity inhibitor of 
TEA uptake (Ki,ap  0.8 ]~M), completely blocked tubular 
TEA efflux for as long as 5 min. The ability of TPeA to 
inhibit carrier-mediated fflux suggests that this compound 
binds to the OC transporter but that subsequent carrier 
turnover occurs very slowly, if at all. In the present study, 
the basis of this trans-inhibition of TEA transport by 
TPeA was examined further in suspensions of rabbit renal 
proximal tubules. 
2. Materials and methods 
2.1. Materials 
[14C]TEA (56 mCi/mmol) and [14C]PAH (49.6 
mCi/mmol) was purchased from New England Nuclear- 
Dupont (Boston, MA). [14C]Glutarate (19 mCi/mmol) 
was purchased from ICN Biochemicals (Costa Mesa, CA). 
Unlabeled TEA and TPeA were purchased from Aldrich 
(Milwaukee, WI). The source of the remaining chemicals 
has been reported previously [8]. 
2.2. Isolation of tubule suspensions 
Suspensions of rabbit renal proximal tubules were iso- 
lated and purified from New Zealand White rabbits by an 
enzymatic ( ollagenase) procedure based on the method of 
Vinay et al. [9] as modified by Groves et al. [8]. The tubule 
pellet was resuspended at a final protein concentration f
10 mg/ml or 1 mg/ml in an incubation medium contain- 
ing (in mM): 1 alanine, 5 dextrose, 2 heptanoic acid, 4 
lactate, 5 malate, 115 NaC1, 15 NaHCO3, 5 KCI, 2 
NaHzPO 4, 1 MgSO 4, 1 CaC12, and 10 N-2-hydroxyethyl- 
piperazine-N'-2-ethanesulfonic acid (Hepes) (pH 7.4, 295 
mosmol/kg). Protein was measured using the Bio-Rad 
protein assay with a y-globulin standard. For [a4C]PAH 
and [14C]glutarate uptake studies, tubules were resus- 
pended at 1 mg/ml in an incubation medium containing 
(in mM): 5 alanine, 0.9 glycine, 8.3 dextrose, 1.5 lactate, 1 
malate, 10 sodium acetate, 1 sodium citrate, 110 NaCI, 2 
NaH2PO4, 5 KC1, 1 MgSO4, 1.8 CaC12 and 25 NaHCO 3 
(pH 7.4, 295 mosmol/kg). This preparation results in an 
enriched population of renal proximal tubules with col- 
lapsed lumens as verified by the measurement of low 
brush border y-GT levels (< 20% of total y-GT) in tubule 
suspensions [10] and by microscopic visual inspection 
(using differential interference ontrast microscopy; Groves 
and Wright, unpublished observations). Therefore, fluxes 
into or out of this preparation reflect transport events 
occurring at the peritubular membrane of proximal cells. 
2.3. Measurement of [14C]TEA uptake in tubule suspen- 
sions 
Tubule suspensions (1 mg/ml) were preincubated in
Erlenmeyer flasks for 15 min at 37°C and gassed with 
95%O2/5%CO 2. [14C]TEA (1.8 /xM) was then added to 
the tubule suspension. At timed intervals from 1 to 30 min, 
0.5 ml aliquots of the suspension were removed, added to 
tubes containing 5 ml of ice-cold 1 mM TPeA (dissolved 
in incubation buffer) to stop uptake, and the samples were 
centrifuged for ~ 25 s at 1480 × g to pellet the tubules. 
The supernatant fraction was aspirated, and the pellet was 
rinsed a second time. The final pellet was dissolved in 1 M 
NaOH, and aliquots were taken for counting radioactivity. 
To examine the kinetics of TEA uptake, tubule suspen- 
sions were preincubated asdescribed above. An aliquot of 
tubule suspension (0.5 ml) was then transferred toa 15-ml 
tube containing 0.5 ml of incubation medium with 7.1 /xM 
[14 C]TEA and increasing concentrations of unlabeled TEA. 
After 30 s uptake was terminated by the addition of 5 ml 
ice-cold incubation buffer containing 1 mM TPeA. The 
tubules were pelleted and prepared for counting radioactiv- 
ity as described. To examine the effect of TPeA on the 
kinetics of TEA uptake, measurements of [14 C]TEA uptake 
with increasing concentrations of unlabeled TEA were 
performed as described in the presence of 2 /zM unlabeled 
TPeA. 
2.4. Measurement of TEA efflux 
For efflux studies, tubules were preloaded with 1.8 /zM 
[14C]TEA for 30 min. Control uptake was measured by 
adding 0.5 ml aliquots to 5 ml of ice-cold 1 mM TPeA. 
Efflux was measured by adding 0.5 ml aliquots to 4.5 ml 
of incubation buffer containing TPeA at concentrations 
ranging from 0 to 500 /zM (consult he figure legends for 
experimental details) after which the incubation was con- 
tinued for 1 to 5 min. The efflux reaction was terminated 
by the addition of 5 ml ice-cold 1 mM TPeA and tubule 
pellets were prepared for counting radioactivity as de- 
scribed above. The efflux of TEA from preloaded tubules 
represents flux across the peritubular membrane since the 
flux across the luminal membrane is believed to represent 
an insignificant portion of the total TEA efflux from 
tubules. 
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2.5. Inhibition of TEA uptake after a brief exposure to 
TPeA or TEA 
TPeA (1 /zM, dissoh,ed in incubation buffer), TEA 
(150 IxM) or incubation buffer alone was added to tubule 
suspensions. After 10 s, tubules were diluted 10-fold with 
incubation buffer containing [14C]TEA (1.8 ~M)  alone or 
[ laG]TEA with 0.1 /xM TPeA or 15 /~M TEA (control). 
At timed intervals, uptake was measured as described 
above. The control condition consisted of uptake measured 
in the presence of 0.1 ~M TPeA or 15 /xM TEA in 
tubules which were not preincubated with these OCs. 
For recovery experiments, TPeA (1 /zM) or incubation 
buffer alone was added to suspensions. After 10 s, tubules 
were diluted 10-fold with incubation buffer alone or 0.1 
~M TPeA (control), and the incubation continued for 10 
min. [ laC]TEA (1.8 /xM) was then added to suspensions 
and uptake measured as described above. 
2.6. [Vleasurement of[14 C]PAH and [14 C]glutarate uptake 
in tubule suspensions 
Tubule suspensions (i mg/ml) were preincubated in
Erlenmeyer flasks for 15 min at 37°C and gassed with 
95%O2/5%CO 2.An aliquot of tubule suspension (0.5 ml) 
was then transferred to a 15-ml tube containing 0.5 ml of 
incubation medium with [14C]PAH (8.1 /~M) or 
[14C]glutarate (21.1 /zM) and increasing concentrations of 
unlabeled TPeA. After 30 s uptake was terminated by the 
addition of 5 ml ice-cold Hepes-buffered incubation 
medium (Hepes buffer markedly decreases the uptake of 
PAH and glutarate in tubule suspensions; Groves, unpub- 
lished observations). The tubules were pelleted and pre- 
pared for counting radioactivity as described previously. 
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Fig. 1. Time-dependent accumulation and efflux of TEA from suspen- 
sions of rabbit renal proximal tubules. The bath concentration f [14 C]TEA 
during the uptake period was 1.8 /zM. The efflux of [14C]TEA was 
determined in the absence and presence of 500 /zM trans-TPeA. Each 
point is the mean + S.E. of triplicate measurements from three separate 
tubule preparations. 
3. Results and discussion 
The cumulative uptake of 1.8 /~M [14C]TEA by tubule 
suspensions increased with time and approached a steady 
state level after 10 min (Fig. 1). The efflux of [14C]TEA 
from preloaded tubules was a time-dependent, first order 
reaction with a rate constant of 0.11 min -1 (Fig. 1). This 
rate of efflux was similar to that observed from single 
proximal $2 segments with oil-filled lumens (rate constant 
of 0.10 min-1; [11]), which supports our contention that 
fluxes measured in the tubule suspension represent per- 
itubular events. Our previous report [3] noted that the 
presence in the external medium of 500 tzM TPeA inhib- 
ited efflux of TEA from preloaded tubules. This observa- 
tion is confirmed and extended by the results presented in
Fig. 1. The presence in the external medium of 500 ~M 
TPeA effectively blocked the efflux of TEA for 5 min. 
The ability of 500 /xM TPeA to block the efflux of 
TEA suggests that carder turnover in the presence of this 
high affinity inhibitor occurs slowly, if at all 1. The K i ap 
for inhibition of TEA transport by TPeA is < 1 gM i3~. 
Thus, if TPeA inhibits TEA efflux through its interaction 
at the carrier-site, this effect should be noted at much 
lower concentrations than 500 /zM. Indeed, with a Ki,ap o 
of 0.8 /zM, an external concentration f 10 ~M would be 
expected to occupy > 90% of the carriers and, therefore, 
reduce efflux to a similar extent. To test this hypothesis, 
the effect of lower concentrations of TPeA on TEA efflux 
was examined. Increasing the external concentration of 
TPeA from 0 to 10 /xM did affect the loss of TEA from 
preloaded tubules, reducing the 5 min efflux by approx. 
50% (Fig. 2). Significantly, this degree of inhibition was 
substantially less than the complete block of efflux ob- 
served in studies employing 500 /xM TPeA (e.g., Fig. 1). 
The fact that efflux of TEA from tubules can be com- 
pletely eliminated implies that diffusive loss of TEA from 
tubules is virtually zero. Therefore, the efflux of TEA 
noted in the presence of a near-saturating concentration 
must be occurring via the peritubular OC transporter, 
despite the likelihood that the external aspect of the card- 
ers is bound to TPeA. These data suggest that a TPeA-car- 
rier complex must turnover, albeit at a rate that is slower 
than an unoccupied carrier. In other words, the complete 
block of TEA efflux observed in the presence of 500 /xM 
external TPeA does not arise as a consequence of the 
binding of TPeA to the transport receptor and the subse- 
quent production of a non-translocatable complex. 
When the external TPeA concentration was increased 
from 10/xM to 500/~M, [14C]TEA efflux was reduced by 
a In this context, carder 'turnover' refers to the suite of events 
encompassing the binding of substrate to the carrier, the subsequent 
translocation across/through the membrane of the substrate-carrier com- 
plex, dissociation of substrate from the carder, and reorientation of the 
carrier to the initial aspect of the membrane. 
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Fig. 2. Inhibition of tubular TEA efflux by increasing concentrations of 
TPeA. Tubule suspensions were preloaded with [14C]TEA (1.8 /xM) for 
30 min. Aliquots of [14C]TEA-loaded tubules were transferred to a bath 
containing the indicated concentration f TPeA or incubation buffer alone 
and 5 min efflux was then determined. Efflux is expressed as the percent 
loss of [14 C]TEA from the tubules relative to tubule content at time zero. 
Each point is the mean + S.E. of triplicate measurements from three or 
four separate xperiments. The lines were fit using a non-linear regression 
algorithm (Sigmaplot, Jandel Scientific) to either a one-site (dashed line) 
or two site (solid line) model of TPeA interaction with the TEA trans- 
porter (see text). 
an additional 50% relative to the control level of efflux 
thereby achieving a near-complete inhibition of TEA el- 
flux (Fig. 2). Thus, over the full concentration range 
studied, external TPeA was found to produce a biphasic, 
concentration-dependent trans-inhibition of TEA efflux 
from tubule suspensions. These observations suggest hat 
at low (< 10 /xM) concentrations, TPeA interacts pecifi- 
cally at the TEA transport site, whereas at high (> 10 
/xM) concentrations TPeA produces a separate, presum- 
ably allosteric inhibition of OC transport. The kinetics of 
the inhibition of TEA efflux by TPeA with the OC trans- 
porter also support he existence of a two site model for 
TPeA inhibition. The change in TEA efflux as a function 
of TPeA concentration was adequately described by a two 
site kinetic model of the form: 
Ei = K~0 + [TPeA] + K520 + [TPeA] (1) 
where E i is the inhibition of TEA efflux caused by an 
external concentration f [TPeA]; Ks0 is the concentration 
of TPeA resulting in 50% inhibition of efflux by each of 
the superscripted processes (i.e., process 1 and 2); and the 
E max parameters represent he decrease in total efflux 
contributed by each process. The solid line describing the 
relationship resented in Fig. 2 is the best fit to the data 
according to this model. The dotted line represents he best 
fit assuming a one site model. The systematic deviation of 
the one site model from the measured values for E i argue 
for the presence of at least two sites. The values for K~0 
and K20 were 0.1 and 24/xM, respectively. The values for 
E max1 and Ei m~x2 were 19.8% and 29.3%, respectively 
An alternative xplanation for the failure of 10 /xM 
TPeA to produce a complete block of TEA effiux involves 
the possibility that, from this concentration, TPeA binds to 
the TEA transport site with a comparatively slow on rate; 
i.e., if most of the transporters were to remain unoccupied 
by TPeA during the time course of the efflux period, then 
efflux of TEA could proceed at a sufficient rate to 'mask' 
that fact that 10/zM TPeA may eventually occupy > 90% 
of the transport sites producing a non-translocatable sub- 
strate-carrier complex. To determine whether the associa- 
tion of TPeA with the TEA transporter is particularly slow, 
30 s TEA uptakes were measured in tubules which were 
preincubated for 30 s with increasing concentrations of
TPeA. If association of the transporter with TPeA is slow, 
then preexposure of this ligand to the transport site should 
produce a 'left-shift' (i.e., decrease) of the apparent in- 
hibitory constant for TPeA. This was not the case. The 
apparent K i (i.e., concentration required to reduce TEA 
uptake by 50%) was 1.1 /xM for control tubules vs. 1.0 
/xM for tubules preexposed to TPeA. This result argues 
against he likelihood that the failure of 10 /xM TPeA to 
block efflux of TEA was a consequence of the slow 
binding of this inhibitor to the transporter. 
Separate xperiments addressed the issue of whether the 
inhibitory effects of TPeA on peritubular transport were 
specific for the OC transport pathway. Glutarate and p- 
aminohippurate (PAH) are accumulated by proximal cells 
by separate processes which appear to be unrelated to the 
transport pathway for OCs. Glutarate uptake involves a 
Na-dependent cotransport process pecific for dicarboxyl- 
ates [12,13], and PAH uptake involves the carrier-mediated 
exchange of PAH for dicarboxylates [13-15]. Although 10 
/zM TPeA had no effect on the uptake of [14C]glutarate, 
500 /zM TPeA did result in a 19% (+7%; P < 0.05) 
reduction in glutarate uptake. Uptake of PAH was also 
inhibited by extemal TPeA, although the same degree of 
inhibition (17% _ 6% and 20% -4- 7%) was noted at 10 and 
500 /zM TPeA, respectively. Several other studies have 
noted cross inhibitory interactions between transport path- 
ways for organic cations and organic anions, most notably 
the inhibition of OC transport by OA inhibitors including 
probenecid [16-18]. The authors of these studies uggested 
that these interactions arise from the competitive interac- 
tion of the molecules at the transport receptors. However, 
in the light of the present results showing a secondary, 
possibly allosteric inhibitory interaction of TPeA with the 
OC transporter, the inhibition by TPeA of peritubular PAH 
and glutarate uptake may be the result of a rather non- 
specific interaction of this lipophilic cation with peritubu- 
lar membrane proteins. 
One means by which the binding of TPeA to the OC 
transporter could result in a reduction in net carrier turnover 
is if the dissociation (rather than association) of TPeA 
from the carrier were comparatively slow. If this were so, 
then a TPeA-carrier complex could be unavailable for 
uptake of another substrate for a protracted period of time. 
This hypothesis was tested by measuring the uptake of 
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TEA in tubule suspension,; (10 mg/ml) which were prein- 
cubated for 10 s with 1 ArM TPeA and then diluted 10-fold 
to a final TPeA concentration of 0.1 ArM (Fig. 3). When 
tubules are exposed simultaneously to 1 ArM TPeA and 
[14C]TEA, uptake of TEA is reduced by ~ 50% [3]. 
However, exposure to 0.1 ArM TPeA, a concentration well 
below the gi,ap p for  TPeA, during uptake should reduce 
transport by < 10%. Following dilution, both sets of 
tubules were exposed to the same buffer conditions: radio- 
labeled TEA and a 0.1 ArM concentration f TPeA. How- 
ever, uptake into the tubules that were preexposed for 10 s 
to 1 ArM TPeA was reduced by ~ 30%-50% compared to 
control uptake. This observation is consistent with the 
contention that, once bound, dissociation of TPeA from the 
peritubular OC transporter is a relatively slow process. The 
apparent affinity of the OC transporter for TEA itself is 
much lower than for TPeA; the K t for TEA transport is 
130 ArM, compared to a Ki,ap  for TPeA of 0.8 ArM [3]. 
Thus, dissociation of TEA from the carrier might be 
expe&ed to be more rapid than dissociation of TPeA. If so, 
preexposure of tubules to a comparably arge concentration 
of unlabeled TEA (i.e., 150 ArM) should have no effect on 
the subsequent uptake of [14 C]TEA by the diluted tubule 
suspension. Indeed, as shown in Fig. 3b, this was the case. 
The interaction of TPeA with the transporter was re- 
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Fig. 3. (A) Effect of a brief exposure (10 s) to 1 /zm TPeA on TEA 
uptake. Tubule suspensions (10 mg/ml) were incubated with 1 /xM 
TPeA or incubation buffer (control) for 10 s then diluted 10-fold with 
[14C]'IT~ (1.8 /xM) or [14C]TEA and 0.1 /zM TPeA. The time course of 
[14C]TEA uptake was then measured for each group of tubules. Each 
point is the mean + S.E. of triplicate measurements from four separate 
experiments. (B) Effect of a brief exposure (10 s) to 150 /xM TEA on 
TEA uptake. Tubule suspensions (10 mg/ml) were incubated with 150 
gM TEA or incubation buffer (control) for 10 s then diluted 10-fold with 
[14C]TEA (1.8 /zM) or []4C]TILA and 15 /zM TEA. Each point is the 
mean + S.E. of triplicate measmements from three separate xperiments. 
(C) Recovery of TEA uptake following prolonged inhibition by TPeA. 
Tubule suspensions (10 mg/ml) were incubated with 1 brM TPeA or 
incubation buffer (control) for 10 s, then diluted 10-fold with incubation 
buffer only. After 10 min, [14C]TEA (1.8 p~M) or [14C]TEA+0.1 /zM 
TPeA was added and 30 s uptake measured. Each point is the mean + S.E. 
of triplicate measurements from four separate xperiments. Values with 
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Fig. 4. Effect of TPeA (2 /.~M) on the kinetics of TEA transport in tubule 
suspensions. The uptake of [14C]TEA (7.1 /xM) was measured in the 
presence of increasing concentrations of unlabeled TEA in the presence 
and absence of 2 /xM TPeA. Each point is the mean+S.E, of triplicate 
measurements from six separate xperiments. 
earlier that TPeA does appear to be transported by the OC 
transporter. The uptake of [14C]TEA returned to control 
levels in tubule suspensions which were preincubated with 
1 /xM TPeA for 10 s, diluted to 0.1 ArM and allowed to 
recover for 10 min prior to measuring uptake (Fig. 3c). 
This slow dissociation of TPeA from the OC transporter 
suggests that once bound TPeA may effectively decrease 
the number of sites available for the transport of TEA. 
Kinetically, this event might be expected to be manifest as 
a noncompetitive or mixed type inhibition of TEA trans- 
port. To test this hypothesis, the effect of a 2 ArM concen- 
tration of TPeA on the kinetics ('/max and K t) of TEA 
transport was examined in tubule suspensions (Fig. 4). In 
contrast o our expectations, TPeA increased the K t for 
TEA transport from 170 ArM to 560 ArM but had no effect 
on Jmax, indicating that TPeA is a competitive inhibitor of 
TEA uptake. The calculated K i for TPeA was 0.9 ArM, in 
close agreement with the Ki.ap  of 0.8 ArM for TPeA 
determined previously [3]. As noted above, the observed 
slow dissociation of TPeA from the OC transporter led to 
the expectation that inhibition by TPeA would reduce 
apparent Jmax" The reason for this lack of TPeA effect on 
Jmax is unclear. However, the apparent rapid association 
and subsequent slow dissociation of TPeA with the trans- 
porter was observed in tubules preincubated with TPeA 
alone. The results shown in Fig. 4 suggest that large 
concentrations of TEA are capable of displacing TPeA 
from the binding site(s) it occupies, thereby permitting 
TEA to compete ffectively for transport. 
Collectively, these observations show that the interac- 
tions of TPeA, and perhaps similarly large hydrophobic 
OCs, with the OC transport system are complex. TPeA 
appears to inhibit peritubular OC transport in rabbit renal 
proximal tubules through interaction with a high affinity 
and a low affinity binding site. At the high affinity site, 
TPeA appears to bind rapidly but is slow to dissociate, 
producing a prolonged inhibition of uptake. This effect 
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may be overcome by increasing the concentration f TEA. 
These interactions may be related to either the compara- 
tively large size and/or hydrophobic nature of TPeA. A 
number of reports have documented significant, and some- 
times deleterious, interactions of cationic drugs at the site 
of renal secretion (e.g., [19-22]). Some of these interacting 
agents (e.g., cimetidine) have been found to interact with 
renal OC transporters with very high affinity (e.g., [23]). 
The present results suggest hat the nature of such drug 
interactions may be more complex than previously as- 
sumed. 
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